Skip to main content

Together we are beating cancer

Donate now

Phil Prime

Showing 12 out of 68 results

We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness… We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness…

by Phil Prime | Interview | 10 April 2022

10 April 2022

We answer questions from the research community about our refreshed Research Strategy We answer questions from the research community about our refreshed Research Strategy

by Phil Prime | Interview | 29 March 2022

29 March 2022

The episode features Steve Jackson. Steve is the University of Cambridge Frederick James Quick Professor of Biology. He is also Head of Cancer Research UK Laboratories at the Wellcome Trust/Cancer Research UK Gurdon Institute. He talks about the difference between academic and commercial science, tips for forming a spinout company and what we should aim for in the next 20 years of cancer research. The episode features Steve Jackson. Steve is the University of Cambridge Frederick James Quick Professor of Biology. He is also Head of Cancer Research UK Laboratories at the Wellcome Trust/Cancer Research UK Gurdon Institute. He talks about the difference between academic and commercial science, tips for forming a spinout company and what we should aim for in the next 20 years of cancer research.

by Phil Prime | Podcast | 23 March 2022

23 March 2022

This entry is part 2 of 9 in the series Cancer Research Matters - series 1
Vivian Li, group leader of the stem cell and cancer biology lab at the Francis Crick Institute

Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments. Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments.

by Phil Prime | In depth | 11 February 2022

11 February 2022

The first episode features Ruth Plummer. Ruth is Professor of Experimental Cancer Medicine at Newcastle University and Director of the CRUK Newcastle Cancer Centre. She talks about how the DNA repair inhibition field has changed over 20 years, her instrumental role in the development of the PARP inhibitor Rucaparib and why work/life balance is so important for the future of research life. The first episode features Ruth Plummer. Ruth is Professor of Experimental Cancer Medicine at Newcastle University and Director of the CRUK Newcastle Cancer Centre. She talks about how the DNA repair inhibition field has changed over 20 years, her instrumental role in the development of the PARP inhibitor Rucaparib and why work/life balance is so important for the future of research life.

by Phil Prime | Podcast | 4 February 2022

4 February 2022

This entry is part 1 of 9 in the series Cancer Research Matters - series 1

Two of our Research Committee Chairs take stock of the incredible science done over 2021 and tell us what they are excited about in the year to come Two of our Research Committee Chairs take stock of the incredible science done over 2021 and tell us what they are excited about in the year to come

by Phil Prime | Analysis | 21 January 2022

21 January 2022

Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers... Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers...

by Phil Prime | In depth | 13 December 2021

13 December 2021

We speak with two science communication masters about the benefits, ethics and sheer fun of communicating your research to the public. We speak with two science communication masters about the benefits, ethics and sheer fun of communicating your research to the public.

by Phil Prime | In depth | 22 November 2021

22 November 2021

On LGBTQ+ STEM day, we hear from two Cancer Research UK scientists on the power of diversity and why bringing your full self to your research is so important… On LGBTQ+ STEM day, we hear from two Cancer Research UK scientists on the power of diversity and why bringing your full self to your research is so important…

by Phil Prime | In depth | 18 November 2021

18 November 2021

This entry is part 6 of 8 in the series Diversity in research
Eithne Costello

Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important. Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important.

by Phil Prime | Interview | 12 November 2021

12 November 2021

We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment

by Phil Prime | Interview | 2 November 2021

2 November 2021